MARROW FAILURE: VIRUS-INDUCED DISEASE

骨髓衰竭:病毒引起的疾病

基本信息

  • 批准号:
    3343026
  • 负责人:
  • 金额:
    $ 15.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1983
  • 资助国家:
    美国
  • 起止时间:
    1983-09-30 至 1986-11-30
  • 项目状态:
    已结题

项目摘要

Aplastic anemia in man is a complex disorder of multiple causes. Among them are direct stem cell damage by agents such as ionizing radiation, immunologically-mediated damage, direct viral effects on progenitor cells, and neoplastic transformation of the myeloid stem cell. To better understand some of the mechanisms involved in aplasia, we have developed an animal model of feline leukemia virus (FeLV)-induced marrow failure (pure red cell aplasia). We have deliberately infected immmunosuppressed animals and produced severe anemia. To assess the level at which FeLV induces marrow failure, we have developed clonogenic assays for various hematopoietic progenitor cells in culture. To be able to detect neoplastic transformation and the possibility that marrow failure results from a neoplastic myeloid or lymphoid cell population, we have bred domestic and wild type (Geoffroy) cats having different G-6-PD enzyme types. The F1 females are stable G-6-PD heterozygotes and we have demonstrated X-chromosome inactivation. Through a combination of both in vitro and in vivo studies, we will examine the effects of virus on hematopoietic progenitor cell growth, the possibility that auxiliary cells are involved in the process of marrow suppression, and determine whether marrow failure results from the clonal expansion of a neoplastic myeloid stem cell or a lymphoid neoplasm.
再生障碍性贫血是一种由多种原因引起的复杂疾病。在

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN W ADAMSON其他文献

JOHN W ADAMSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN W ADAMSON', 18)}}的其他基金

SMALL INSTRUMENTATION GRANT
小型仪器补助金
  • 批准号:
    2231695
  • 财政年份:
    1994
  • 资助金额:
    $ 15.34万
  • 项目类别:
PROLIFERATION AND DIFFERENTIATION OF ISOLATED STEM CELLS
分离的干细胞的增殖和分化
  • 批准号:
    3365640
  • 财政年份:
    1991
  • 资助金额:
    $ 15.34万
  • 项目类别:
PROLIFERATION AND DIFFERENTIATION OF ISOLATED STEM CELLS
分离的干细胞的增殖和分化
  • 批准号:
    3365642
  • 财政年份:
    1991
  • 资助金额:
    $ 15.34万
  • 项目类别:
PROLIFERATION AND DIFFERENTIATION OF ISOLATED STEM CELLS
分离的干细胞的增殖和分化
  • 批准号:
    3365641
  • 财政年份:
    1991
  • 资助金额:
    $ 15.34万
  • 项目类别:
PROLIFERATION AND DIFFERENTIATION OF ISOLATED STEM CELLS
分离的干细胞的增殖和分化
  • 批准号:
    2223012
  • 财政年份:
    1991
  • 资助金额:
    $ 15.34万
  • 项目类别:
PATHOBIOLOGY OF BONE MARROW SUPPRESSION IN AIDS OR ARC
艾滋病或 ARC 骨髓抑制的病理学
  • 批准号:
    3242929
  • 财政年份:
    1989
  • 资助金额:
    $ 15.34万
  • 项目类别:
PATHOBIOLOGY OF BONE MARROW SUPPRESSION IN AIDS OR ARC
艾滋病或 ARC 骨髓抑制的病理学
  • 批准号:
    3242930
  • 财政年份:
    1989
  • 资助金额:
    $ 15.34万
  • 项目类别:
PATHOBIOLOGY OF BONE MARROW SUPPRESSION IN AIDS OR ARC
艾滋病或 ARC 骨髓抑制的病理学
  • 批准号:
    3242931
  • 财政年份:
    1989
  • 资助金额:
    $ 15.34万
  • 项目类别:
PATHOBIOLOGY OF BONE MARROW SUPPRESSION IN AIDS OR ARC
艾滋病或 ARC 骨髓抑制的病理学
  • 批准号:
    3242932
  • 财政年份:
    1989
  • 资助金额:
    $ 15.34万
  • 项目类别:
GROWTH FACTORS IN NORMAL AND NEOPLASTIC HEMATOPOIESIS
正常和肿瘤造血中的生长因子
  • 批准号:
    3169705
  • 财政年份:
    1982
  • 资助金额:
    $ 15.34万
  • 项目类别:

相似海外基金

Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
  • 批准号:
    10722602
  • 财政年份:
    2022
  • 资助金额:
    $ 15.34万
  • 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
  • 批准号:
    10368246
  • 财政年份:
    2022
  • 资助金额:
    $ 15.34万
  • 项目类别:
Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells
Eltombopag:对正常和再生障碍性贫血造血干细胞的新作用模式
  • 批准号:
    10676888
  • 财政年份:
    2022
  • 资助金额:
    $ 15.34万
  • 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
  • 批准号:
    10600143
  • 财政年份:
    2022
  • 资助金额:
    $ 15.34万
  • 项目类别:
The effects of somatic HLA class I allele mutations on antigen presentation in acquired aplastic anemia
体细胞 HLA I 类等位基因突变对获得性再生障碍性贫血抗原呈递的影响
  • 批准号:
    10347646
  • 财政年份:
    2022
  • 资助金额:
    $ 15.34万
  • 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
  • 批准号:
    10370775
  • 财政年份:
    2022
  • 资助金额:
    $ 15.34万
  • 项目类别:
The effects of somatic HLA class I allele mutations on antigen presentation in acquired aplastic anemia
体细胞 HLA I 类等位基因突变对获得性再生障碍性贫血抗原呈递的影响
  • 批准号:
    10545024
  • 财政年份:
    2022
  • 资助金额:
    $ 15.34万
  • 项目类别:
Identification of autoantigens presented by specific HLA class I alleles in aplastic anemia
再生障碍性贫血中特定 HLA I 类等位基因呈现的自身抗原的鉴定
  • 批准号:
    19H03686
  • 财政年份:
    2019
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of novel genes related to aplastic anemia using mouse models.
使用小鼠模型对与再生障碍性贫血相关的新基因进行功能分析。
  • 批准号:
    19K08297
  • 财政年份:
    2019
  • 资助金额:
    $ 15.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了